SLC7A5/LAT1 was found overexpressed in a wide range of solid tumors including the most frequently diagnosed cancers such as breast cancer [13,14], prostate cancer [15,16,17], and lung cancer [18,19,20,21,22,23,24,25,26,27,28,29,30]. Here, SLC7A5 is linked to prostate carcinoma.